Cargando…

SDF-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects

BACKGROUND: The effects of atorvastatin on SDF-1α expression under acute myocardial infarction (AMI) are still unclear. Therefore, our present study is to investigate the roles and mechanisms of atorvastatin treatment on SDF-1α expression in rats with AMI. METHODS: Male Sprague–Dawley rats were unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Ruofeng, Cai, Anping, Dong, Yugang, Zhou, Yingling, Yu, Danqing, Huang, Yuli, Zheng, Dongdan, Rao, Shaoqi, Feng, Yingqing, Mai, Weiyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533954/
https://www.ncbi.nlm.nih.gov/pubmed/23170833
http://dx.doi.org/10.1186/1423-0127-19-99
_version_ 1782254493525606400
author Qiu, Ruofeng
Cai, Anping
Dong, Yugang
Zhou, Yingling
Yu, Danqing
Huang, Yuli
Zheng, Dongdan
Rao, Shaoqi
Feng, Yingqing
Mai, Weiyi
author_facet Qiu, Ruofeng
Cai, Anping
Dong, Yugang
Zhou, Yingling
Yu, Danqing
Huang, Yuli
Zheng, Dongdan
Rao, Shaoqi
Feng, Yingqing
Mai, Weiyi
author_sort Qiu, Ruofeng
collection PubMed
description BACKGROUND: The effects of atorvastatin on SDF-1α expression under acute myocardial infarction (AMI) are still unclear. Therefore, our present study is to investigate the roles and mechanisms of atorvastatin treatment on SDF-1α expression in rats with AMI. METHODS: Male Sprague–Dawley rats were underwent permanent coronary artery ligation and randomly assigned into four groups as follow: blank control (B), atorvastatin (A), atorvastatin plus L-NAME (A+L-NAME), and atorvastatin plus AMD3100 (A+AMD3100). Rats underwent similar procedure but without ligation were used as group sham operated (S). Atorvastatin (10mg/Kg/d body weight) was administrated by gavage to rats in three atorvastatin treated groups, and L-NAME (40mg/Kg/d body weight) or AMD3100 (5mg/Kg/d body weight) was given to group A+L-NAME or A+AMD3100, respectively. RESULTS: Comparing with group B, NO production, SDF-1α and CXCR4 expression were significantly up-regulated in three atorvastatin treated groups at the seventh day. However, the increments of SDF-1α and CXCR4 expression in group A+L-NAME were reduced when NO production was inhibited by L-NAME. Anti-inflammatory and anti-apoptotic effects of atorvastatin were offset either by decrease of SDF-1α and CXCR4 expression (by L-NAME) or blockage of SDF-1α coupling with CXCR4 (by AMD3100). Expression of STAT3, a cardioprotective factor mediating SDF-1α/CXCR4 axis induced cardiac protection, was up-regulated most significantly in group A. The effects of atorvastatin therapy on cardiac function were also abrogated either when SDF-1α and CXCR4 expression was diminished or the coupling of SDF-1α with CXCR4 was blocked. CONCLUSION: SDF-1α upregulation by atorvastatin in rats with AMI was, at least partially, via the eNOS/NO dependent pathway, and SDF-1α upregulation and SDF-1α coupling with CXCR4 conferred anti-inflammatory and anti-apoptotic effects under AMI setting which we speculated that ultimately contributed to cardiac function improvement.
format Online
Article
Text
id pubmed-3533954
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35339542013-01-07 SDF-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects Qiu, Ruofeng Cai, Anping Dong, Yugang Zhou, Yingling Yu, Danqing Huang, Yuli Zheng, Dongdan Rao, Shaoqi Feng, Yingqing Mai, Weiyi J Biomed Sci Research BACKGROUND: The effects of atorvastatin on SDF-1α expression under acute myocardial infarction (AMI) are still unclear. Therefore, our present study is to investigate the roles and mechanisms of atorvastatin treatment on SDF-1α expression in rats with AMI. METHODS: Male Sprague–Dawley rats were underwent permanent coronary artery ligation and randomly assigned into four groups as follow: blank control (B), atorvastatin (A), atorvastatin plus L-NAME (A+L-NAME), and atorvastatin plus AMD3100 (A+AMD3100). Rats underwent similar procedure but without ligation were used as group sham operated (S). Atorvastatin (10mg/Kg/d body weight) was administrated by gavage to rats in three atorvastatin treated groups, and L-NAME (40mg/Kg/d body weight) or AMD3100 (5mg/Kg/d body weight) was given to group A+L-NAME or A+AMD3100, respectively. RESULTS: Comparing with group B, NO production, SDF-1α and CXCR4 expression were significantly up-regulated in three atorvastatin treated groups at the seventh day. However, the increments of SDF-1α and CXCR4 expression in group A+L-NAME were reduced when NO production was inhibited by L-NAME. Anti-inflammatory and anti-apoptotic effects of atorvastatin were offset either by decrease of SDF-1α and CXCR4 expression (by L-NAME) or blockage of SDF-1α coupling with CXCR4 (by AMD3100). Expression of STAT3, a cardioprotective factor mediating SDF-1α/CXCR4 axis induced cardiac protection, was up-regulated most significantly in group A. The effects of atorvastatin therapy on cardiac function were also abrogated either when SDF-1α and CXCR4 expression was diminished or the coupling of SDF-1α with CXCR4 was blocked. CONCLUSION: SDF-1α upregulation by atorvastatin in rats with AMI was, at least partially, via the eNOS/NO dependent pathway, and SDF-1α upregulation and SDF-1α coupling with CXCR4 conferred anti-inflammatory and anti-apoptotic effects under AMI setting which we speculated that ultimately contributed to cardiac function improvement. BioMed Central 2012-11-21 /pmc/articles/PMC3533954/ /pubmed/23170833 http://dx.doi.org/10.1186/1423-0127-19-99 Text en Copyright ©2012 Qiu et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Qiu, Ruofeng
Cai, Anping
Dong, Yugang
Zhou, Yingling
Yu, Danqing
Huang, Yuli
Zheng, Dongdan
Rao, Shaoqi
Feng, Yingqing
Mai, Weiyi
SDF-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects
title SDF-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects
title_full SDF-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects
title_fullStr SDF-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects
title_full_unstemmed SDF-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects
title_short SDF-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects
title_sort sdf-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533954/
https://www.ncbi.nlm.nih.gov/pubmed/23170833
http://dx.doi.org/10.1186/1423-0127-19-99
work_keys_str_mv AT qiuruofeng sdf1aupregulationbyatorvastatininratswithacutemyocardialinfarctionvianitricoxideproductionconfersantiinflammatoryandantiapoptoticeffects
AT caianping sdf1aupregulationbyatorvastatininratswithacutemyocardialinfarctionvianitricoxideproductionconfersantiinflammatoryandantiapoptoticeffects
AT dongyugang sdf1aupregulationbyatorvastatininratswithacutemyocardialinfarctionvianitricoxideproductionconfersantiinflammatoryandantiapoptoticeffects
AT zhouyingling sdf1aupregulationbyatorvastatininratswithacutemyocardialinfarctionvianitricoxideproductionconfersantiinflammatoryandantiapoptoticeffects
AT yudanqing sdf1aupregulationbyatorvastatininratswithacutemyocardialinfarctionvianitricoxideproductionconfersantiinflammatoryandantiapoptoticeffects
AT huangyuli sdf1aupregulationbyatorvastatininratswithacutemyocardialinfarctionvianitricoxideproductionconfersantiinflammatoryandantiapoptoticeffects
AT zhengdongdan sdf1aupregulationbyatorvastatininratswithacutemyocardialinfarctionvianitricoxideproductionconfersantiinflammatoryandantiapoptoticeffects
AT raoshaoqi sdf1aupregulationbyatorvastatininratswithacutemyocardialinfarctionvianitricoxideproductionconfersantiinflammatoryandantiapoptoticeffects
AT fengyingqing sdf1aupregulationbyatorvastatininratswithacutemyocardialinfarctionvianitricoxideproductionconfersantiinflammatoryandantiapoptoticeffects
AT maiweiyi sdf1aupregulationbyatorvastatininratswithacutemyocardialinfarctionvianitricoxideproductionconfersantiinflammatoryandantiapoptoticeffects